Clinical Implications of Polymicrobial Synergism Effects on Antimicrobial Susceptibility

Area of Science:

• Microbiology
• Infectious Diseases
• Antimicrobial Resistance

Background:

• Next-generation sequencing reveals polymicrobial infections in chronic conditions like wounds, cystic fibrosis, and otitis media.
• These complex infections are linked to treatment failure and poorer patient prognoses.
• Current antimicrobial susceptibility testing (AST) relies on single-organism analysis, neglecting polymicrobial interactions.

Purpose of the Study:

• To review current research on polymicrobial synergism impacting antimicrobial susceptibility.
• To highlight the effects of inter- and intra-kingdom microbial interactions on treatment outcomes.
• To emphasize the need for novel AST methods for polymicrobial infections.

Main Methods:

• Literature review of studies investigating polymicrobial infections and their impact on antimicrobial susceptibility.
• Analysis of research on microbial synergism, including resistance and tolerance mechanisms.
• Synthesis of findings on inter- and intra-kingdom microbial interactions.

Main Results:

• Microorganisms in polymicrobial environments exhibit synergistic activities that alter antimicrobial susceptibility.
• Both resistance and tolerance mechanisms are influenced by microbial interactions.
• Polymicrobial synergism can lead to treatment challenges and impact patient prognoses.

Conclusions:

• Polymicrobial infections are a significant clinical challenge, often underestimated by current diagnostic methods.
• Understanding microbial synergism is crucial for developing effective treatment strategies.
• Developing new AST systems for polymicrobial infections could significantly improve patient care and outcomes.